Esterase-sensitive nitric oxide donors of the diazeniumdiolate family: In vitro antileukemic activity

Journal of Medicinal Chemistry

Volumn 43, Issue 2, 2000, Pages 261-269

  Saavedra, Joseph E ^a   Shami, Paul J ^b   Wang, Lai Yi ^b   Davies, Keith M ^c   Booth, Melissa N ^d   Citro, Michael L ^a   Keefer, Larry K ^d  

^a SAIC FREDERICK INC   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c GEORGE MASON UNIVERSITY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEUKEMIC AGENT; NITRIC OXIDE; O2 (ACETOXYMETHYL) 1 (N,N DIETHYLAMINO)DIAZEN 1 IUM 1,2 DIOLIC ACID; O2 (ACETOXYMETHYL) 1 (PYRROLIDIN 1 YL)DIAZEN 1 IUM 1,2 DIOLIC ACID; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYDROLYSIS; LEUKEMIA CELL;

ANIMALS; APOPTOSIS; CELL DIVISION; ESTERASES; HL-60 CELLS; HUMANS; HYDROLYSIS; IMIDES; LEUKEMIA; NITRIC OXIDE DONORS; RATS; U937 CELLS;

EID: 0034719333     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9903850     Document Type: Article

References (13)

1. Keefer, L. K.; Nims, R. W.; Davies, K. M.; Wink, D. A. "NO-NOates" (1-Substituted Diazen-1-ium-1,2-diolates) as Nitric Oxide Donors: Convenient Nitric Oxide Dosage Forms. Methods Enzymol. 1996, 268, 281-293.
2. Keefer, L. K. Nitric Oxide-Releasing Compounds: From Basic Research to Promising Drugs. CHEMTECH 1998, 28, 30-35.
3. 2N-[N(O)NO]-. O-Functionalization Chemistry. J. Org. Chem. 1992, 57, 6134-6138.
4. Lefebvre, I.; Périgaud, C.; Pompon, A.; Aubertin, A.-M.; Girardet, J.-L.; Kirn, A.; Gosselin, G.; Imbach, J.-L. Mononucleoside Phosphotriester Derivatives with S-Acyl-2-thioethyl Bioreversible Phosphate-Protecting Groups: Intracellular Delivery of 3′-Azido-2′,3′-dideoxythymidine 5′-monophosphate. J. Med. Chem. 1995, 38, 3941-3950.
5. Saavedra, J. E.; Billiar, T. R.; Williams, D. L.; Kim, Y.-M.; Watkins, S. C.; Keefer, L. K. Targeting Nitric Oxide (NO) Delivery in Vivo. Design of a Liver-Selective NO Donor Prodrug That Blocks Tumor Necrosis Factor-α-Induced Apoptosis and Toxicity in the Liver. J. Med. Chem. 1997, 40, 1947-1954.
6. a of the thiol group in cysteine is 8.3. See: Zubay, G. L. Biochemistry, 4th ed.; Wm. C. Brown: Dubuque, IA, 1998; p 64.
7. Shami, P. J.; Sauls, D. L.; Weinberg, J. B. Schedule and Concentration-Dependent Induction of Apoptosis in Leukemia Cells by Nitric Oxide. Leukemia 1998, 12, 1461-1466.
8. Griffith, O. W.; Kilbourn, R. G. Design of Nitric Oxide Synthase Inhibitors and Their Use to Reverse Hypotension Associated with Cancer Immunotherapy. Adv. Enzyme Regul. 1997, 37, 171-194.
9. Shahidi, H.; Kilbourn, R. G. The Role of Nitric Oxide in Interleukin-2 Therapy Induced Hypotension. Cancer Metastasis Rev. 1998, 17, 119-126.
10. Maragos, C. M.; Morley, D.; Wink, D. A.; Dunams, T. M.; Saavedra, J. E.; Hoffman, A.; Bove, A. A.; Isaac, L.; Hrabie, J. A.; Keefer, L. K. Complexes of ·NO with Nucleophiles as Agents for the Controlled Biological Release of Nitric Oxide. Vasorelaxant Effects. J. Med. Chem. 1991, 34, 3242-3247.
11. Granger, D. L.; Anstey, N. M.; Miller, W. C.; Weinberg, J. B. Measuring Nitric Oxide Production in Human Clinical Studies. Methods Enzymol. 1999, 301, 49-61,
12. Nicoletti, I.; Migliorati, G.; Pagliacci, M. C.; Grignani, F.; Riccardi, C. A Rapid and Simple Method for Measuring Thymocyte Apoptosis by Propidium Iodide Staining and Flow Cytometry. J. Immunol. Methods 1991, 139, 271-279.
13. Darzynkiewicz, Z.; Bruno, S.; Del Bino, G.; Gorczyca, W.; Hotz, M. A.; Lassota, P.; Traganos, F. Features of Apoptotic Cells Measured by Flow Cytometry. Cytometry 1992, 13, 795-808.